Overall rank by patents
#13,910
Across all tracked assignees
USPTO PatentsView assignee record - 21 granted patents across 14 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H05H (PLASMA TECHNIQUE ; PRODUCTION OF ACCELERATED ELECTRICALLY-CHARGED PARTICLES OR OF NEUTRONS; PRODUCTION OR ACCELERATION OF NEUTRAL MOLECULAR OR ATOMIC BEAMS).
The verdict
Cinogy holds 21 US patents across 14 technology areas, rank #13,910 of 50,000 tracked assignees.
Cinogy Gmbh has been granted 21 US utility patents between 2015 and 2025, placing Cinogy Gmbh at rank #13,910 across all assignees tracked by PlainPatent. This portfolio spans 14 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.9 claims per patent with primary concentration in H05H (PLASMA TECHNIQUE ; PRODUCTION OF ACCELERATED ELECTRICALLY-CHARGED PARTICLES OR OF NEUTRONS; PRODUCTION OR ACCELERATION OF NEUTRAL MOLECULAR OR ATOMIC BEAMS). As a Foreign Corporation, Cinogy Gmbh is one of the more focused assignees in the PatentsView dataset. By volume, Cinogy sits between CG BIO Co., Ltd. (21 patents, rank #13,906) and Continuus Materials Intellectual Property, Llc (21 patents, rank #13,914) - the closest US assignees by grant volume. The composite Innovation Score of 34.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 14 grants, compared with 7 in the 2015–2019 window, a +100% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Cinogy Gmbh's 10.9 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 14 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Cinogy Gmbh against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CG BIO CO., LTD.
21 patents
CHANGCHUN INSTITUTE OF OPTICS, FINE MECHANICS AND PHYSICS, CHINESE ACADEMY OF SCIENCES
21 patents
CHINA OILFIELD SERVICES LIMITED
21 patents
CHIROGATE INTERNATIONAL INC.
21 patents
CLASSIC HOME & GARDEN, LLC.
21 patents
COLLIBRA BELGIUM BV
21 patents
CONEXTIONS, INC.
21 patents
CONTINUUS MATERIALS INTELLECTUAL PROPERTY, LLC
21 patents
CINOGY GMBH
21 patents
What this shows Cinogy holds 21 patents at rank #13,910, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #13,910 in granted patent volume.
Other assignees with the most granted patents in Cinogy's primary technology class.
Cinogy's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
34 Top 52% higher than 48% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 9.5% |
| 2016 | 1 | 4.8% |
| 2017 | 1 | 4.8% |
| 2019 | 3 | 14.3% |
| 2020 | 1 | 4.8% |
| 2021 | 6 | 28.6% |
| 2022 | 1 | 4.8% |
| 2023 | 5 | 23.8% |
| 2025 | 1 | 4.8% |
Top 14 of 14 technology areas
Overall rank by patents
#13,910
Across all tracked assignees
34.5 out of 100
How to use this portfolio
Cinogy's 21 grants land it in the top 52% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.